Angiotensinogen and transforming growth factor β1: novel genes in the pathogenesis of Crohn’s disease
Authors:
- 17 October 2006
- journal article
- Published by BMJ in Journal of Medical Genetics
- Vol. 43 (10) , e51
Abstract
Background: Angiotensin peptides may act locally as cytokines in several organ systems with elevated mucosal levels present in Crohn’s disease. A variant in the angiotensinogen gene promoter results in increased peptide production, while transforming growth factor β1 (TGFβ1) codon 25 variants demonstrate variable peptide production, predisposing to fibrosis in several organs. Aims: Conduct an Australian-based analysis of the angiotensinogen-6 variant in two independent inflammatory bowel disease (IBD) cohorts, and examine the role of angiotensinogen-6 and TGFβ1 codon 25 variants in shaping Crohn’s disease phenotype. Methods: IBD Patients (Crohn’s disease = 347, ulcerative colitis = 147) and CD families (n = 148) from two cohorts, together with 185 healthy controls were genotyped for angiotensinogen-6. Genotype-phenotype analyses were performed for both angiotensinogen-6 and TGFβ1 codon 25. Results: Angiotensinogen-6 AA genotype was significantly associated with Crohn's disease (p = 0.007, OR = 2.38, CI = 1.32–4.32) in cohort 1, but not in the smaller cohort 2 (p = 0.19). The association remained significant when the two cohorts were combined (p = 0.008), and in a TDT family analysis (p = 0.03). TGF 1 codon 25 was associated with stricturing Crohn’s disease (p = 0.01, OR = 2.63, CI = 1.16–5.88) and a shorter time to intestinal resection (p = 0.06). Conclusions: The association of the angiotensinogen-6 variant with Crohn’s disease supports a potential role for angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in disease treatment.Keywords
This publication has 35 references indexed in Scilit:
- TNFα and IL10 SNPs act together to predict disease behaviour in Crohn’s diseaseJournal of Medical Genetics, 2005
- Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout miceGut, 2005
- Vascular inflammation: a role in vascular disease in hypertension?Current Opinion in Nephrology and Hypertension, 2003
- Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidneyKidney International, 2002
- Interactions of Transforming Growth Factor-β and Angiotensin II in Renal FibrosisHypertension, 1998
- A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro.Journal of Clinical Investigation, 1997
- What Models of Granulomatous Inflammation Provide the ImmunologistMethods, 1996
- Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.Journal of Clinical Investigation, 1994
- Molecular basis of human hypertension: Role of angiotensinogenCell, 1992
- Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.Journal of Clinical Investigation, 1986